Handbook of Drug Monitoring Methods

Handbook of Drug Monitoring Methods-1

Edited by Amitava Dasgupta 2008 Therapeutics and Drugs of Abuse Starting from the 1970s, therapeutic drug monitoring has evolved from monitoring concentrations of a few antiepileptic drugs to a major discipline in today’s laboratory practice. For a drug with a narrow therapeutic range, therapeutic drug monitoring becomes an essential part of patient management, especially because of the development of […]

Continue reading →

Bortezomib in the Treatment of Multiple Myeloma

Bortezomib in the Treatment of Multiple Myeloma-1

Irene M. Ghobrial, Paul G. Richardson, Kenneth C. Anderson Editors 2011 The proteasome is a highly conserved multicatalytic protease that is responsible for cellular protein turnover, and several therapeutic agents have been developed that specifically target the proteasome. This truly targeted therapy has significantly altered the management of patients with Multiple Myeloma and improved survival.

Continue reading →

Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation

Turning up the Heat on Pain.TRPV1 Receptors in Pain and Inflammation-1

Annika B. Malmberg Keith R. Bley Editors 2005 Despite tremendous advances in the understanding of the sensory nervous system which have accompanied the recent explosive growth of the neurosciences, remarkably few innovative medicines directed towards pain and inflammation are available. Indeed, many patients are still prescribed analgesic and anti-inflammatory medications that were identified long ago as components of herbal […]

Continue reading →

Sodium Channels, Pain, and Analgesia

Sodium Channels, Pain, and Analgesia-1

Kevin Coward Mark D. Baker Editors 2005 The treatment of chronic pain, for example that resulting from damage or dysfunction of the nervous system, or that associated with cancer, is at present inadequate and pain still represents a serious unmet clinical need. The costs of pain, in terms of personal anguish, finance and in national healthcare costs are […]

Continue reading →

Atherosclerosis: Diet and Drugs

Atherosclerosis.Diet and Drugs-1

Editor Arnold von Eckardstein 2005 Cardiovascular diseases continue to be the leading cause of death in the majority of industrialized countries. The most frequent underlying pathology, namely atherosclerosis, and its clinical sequelae, namely coronary heart disease, cerebrovascular disease and peripheral artery disease, remain common although for a long time we have been made aware of avoidable or modifiable etiological factors […]

Continue reading →

Contrast Media

Contrast Media-1

H. S. Thomsen (Ed.) 2006 Safety Issues and ESUR Guidelines The European Society of Urogenital Radiology established its Contrast Media Safety Committee in 1994. Over the years it has consisted of between 12 and 14 members, the majority of whom are experts in the field of contrast media research. There is currently one member from the scientific section of […]

Continue reading →